Of note, among the genes implicated in prostate carcinogenesis and resistance to therapy, such as matrix metalloproteinase (MMP)-11, androgen receptor, and interleukin (IL)-17 receptor beta, were genes coexpressed by tumor-associated fibroblasts and tumor cells [11]. Here, MMP11 is linked to neoplasm.